Липидкоррегирующая фармакотерапия атрибут каротидного субклинического атеросклероза

Липидкоррегирующая фармакотерапия атрибут каротидного субклинического атеросклероза

Автор: Панишева Я.А., Галкина М.А., Фатенков О.В., Симерзин В.В., Сытдыков И.Х., Красовская М.А., Гаглоев А.В., Малыхина Т.В.

Журнал: Вестник медицинского института "РЕАВИЗ": реабилитация, врач и здоровье @vestnik-reaviz

Рубрика: Клиническая медицина

Статья в выпуске: 1 (37), 2019 года.

Бесплатный доступ

В работе представлена характеристика субклинического каротидного атеросклероза, как фактора риска ишемического инсульта. Дана оценка дуплексному сканированию артерий брахиоцефального соединения, как современной неинвазивной инновационной технологии диагностики каротидного субклинического атеросклероза. Отражены принципы агрессивной липидкоррегирующей фармакотерапии статинами.

Короткий адрес: https://sciup.org/143168479

IDR: 143168479

Список литературы Липидкоррегирующая фармакотерапия атрибут каротидного субклинического атеросклероза

  • Bogousslavsky J, Van M.G., Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first Stroke. Stroke 1988; 19:1083-1092.
  • Foulkes M.A., Wolf P.A., Price T.R., Mohr J.P., Hier D.B. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke. 1988 May;19(5):547-54.
  • Inzitari D., Eliasziw M., Gates P. et al. North American Symptomatic Carotid Endarterectomy Trial Collaborators. The Causes and Risk of Stroke in Patients with Asymptomatic Internal-Carotid-Artery Stenosis. N Engl J Med 2000; 342:1693-1701June 8, 2000 DOI: 10.1056/NEJM200006083422302
  • Диагностика и коррекция нарушений липидного обмена с целью профилактики атеросклероза. Российские рекомендации, VI пересмотр//Атеросклероз и дислипидемии. -2017. -№ 3. -С. 5-22.
  • Marais A.D. Dietary lipid modification for mild and severe dyslipidaemias. Proc Nutr Soc. 2013 May 17:1-5.
  • Sacco R.L., Roberts J.K., Boden-Albala B. et al. Paik M.C.: Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. Stroke 1997;28:929-935.
  • O'Leary D.H., Polak J.F., Kronmal R.A. et al. Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke. 1996 Feb;27(2):224-31.
  • Salonen R., Salonen J.T. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men J. Intern. Med. -1991. -Vol. 229, No 3. -P. 225-231
  • DOI: 10.1111/j.1365-2796.1991.tb00336.x
  • Polak J.F., Person S.D., Wei G.S. et al. Segment-specific association of carotid intima-media thickness with cardiovascular risk factors. The Coronary Artery Risk development in Young Adult (CARDIA) Study, Stroke (2010), 41: pp. 9-15.
  • Arnett D.K., Tyroler H.A., Burke G. et al. Hypertension and subclinical carotid artery atherosclerosis in blacks and whites. The Atherosclerosis Risk in Communities Study. ARIC Investigators. Arch Intern Med. 1996; 156: 1983-1989.
  • Chambless L.E., Heiss G., Folsom A.R. et al. Association of Coronary Heart Disease Incidence with Carotid Arterial Wall Thickness and Major Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. American Journal of Epidemiology. Vol. 146, No 6. P. 483-494.
  • Aguilar-Shea A.L., Gallardo-Mayo C., Garrido-Elustondo S. et al. Carotid intima-media thickness as a screening tool in cardiovascular primary prevention. Eur J Clin Invest 2011; 41:521-526.
  • Rundek T., Arif H., Boden-Albala B. et al. Carotid plaque, a subclinical precursor of vascular events. Neurology. 2008 Apr 1; 70(14): 1200-1207
  • DOI: 10.1212/01.wnl.0000303969.63165.34
  • Chambless L.E., Heiss G., Folsom A.R. et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 1997 Sep 15;146(6):483-94.
  • Simon A., Megnien J.L., Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol 2010;30:182-5.
  • Dijk J.M., van der Graaf Y., Bots M.L., Grobbee D.E., and Algra A. Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: The SMART study. European Heart Journal (2006) 27, 1971-1978
  • DOI: 10.1093/eurheartj/ehl13
  • O'Leary D.H., Polak J.F., Wolfson S.K. Jr. et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke. 1991 Sep;22(9):1155-63.
  • O'Leary D.H., Polak J.F., Kronmal R.A. et al. Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999 Jan 7;340(1):14-22
  • DOI: 10.1056/NEJM199901073400103
  • Bots M.L., Hoes A.W., Koudstaal P.J. et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997 Sep 2;96(5):1432-7.
  • Van der Meer I, Bots M.L., Hofman A., del Sol A.I., van der Kuip D.A., Witteman J.C. 2004. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam study. Circulation 109: 1089-94.
  • Ludwig M., von Petzinger, Kruthoff A., von Buquoy M., Stumpe K.O. Intima media thickness of the carotid arteries: early pointer to arteriosclerosis and therapeutic endpoint. Ultraschall Med. 2003 Jun;24(3):162-74
  • Greenland P., Alpert J.S., Beller G.A. et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines/J. Am. Coll. Cardiol. -2010. -Vol. 56, No 25. -P. 50-103
  • DOI: 10.1016/j.jacc.2010.09.001
  • Piepoli M.F., Hoes A.W., Agewall S. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol. 2016 Jul.
  • Wattanakit K., Folsom A.R., Chambless L.E., Nieto F.J. Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2005;149(4):606-612.
  • Wilson P.W., Hoeg J.M., D’Agostino R.B., Silbershatz H., Belanger A.M., Poehlmann H., O’Leary D., Wolf P.A. Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N Engl J Med. 1997;377:516-522.
  • Wasserman B.A., Sharrett A.R., Lai S. et al. Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the Multi-Ethnic Study of Atherosclerosis (MESA). Stroke. 2008;39:329-335
  • DOI: 10.1161/STROKEAHA.107.498634
  • Kurth T., Everett B.M., Buring J.E. et al. Lipid levels and the risk of ischemic stroke in women. Neurology. 2007;68:556-562
  • Shahar E., Chambless L.E., Rosamond W.D. et al. Plasma lipid profile and incident ischemic Stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2003;34:623-631
  • DOI: 10.1161/01.STR.0000057812.51734.FF
  • Lewington S., Whitlock G., Clarke R. et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007 Dec 1;370(9602):1829-39
  • DOI: 10.1016/S0140-6736(07)61778-4
  • Iso H., Jacobs D.R. Jr., Wentworth D., Neaton J.D., Cohen J.D. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989 Apr 6;320(14):904-10
  • DOI: 10.1056/NEJM198904063201405
  • Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet. 1995;346:1647-53.
  • Toth P.P. Subclinical atherosclerosis: what it is, what it means and what we can do about it. International Journal of Clinical Practice 2008; 62 (8): 1246-1254.
  • Williams K.J., Feig J.E., Fisher E.A. Rapid Regression of Atherosclerosis: Insights From the Clinical and Experimental Literature. Nat Clin Pract Cardiovasc Med 2008; 5 (2): 91-102.
  • Pitt B., Byington R.P., Furberg C.D. et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation. 2000 Sep 26;102(13):1503-10.
  • Matsuoka H. STONE study and INSIGHT study: efficacy of nifedipine in the prevention of cardiovascular disease in hypertensive patients. Drugs 2006;66 Spec No 1:13-5.
  • Gariepy J., Simon A., Chironi G., Moyse D., Levenson J.: Large artery wall thickening and its determinants under antihypertensive treatment: the IMT-INSIGHT Study. J Hypertens 2004, 22:137-143.
  • Shimokawa H. ACTION study: efficacy of nifedipine in preventing cardiovascular disease in patients with coronary artery disease. Drugs 2006;66 Spec No 1:10-2.
  • Hedblad B., Wikstrand J., Janzon L., Wedel H., Berglund G. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation. 2001;103:1721-1726.
  • Crouse J.R. 3rd, Raichlen J.S., Riley W.A., Evans G.W., Palmer M.K., O'Leary D.H., Grobbee D.E., Bots M.L.; METEOR Study Group. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA. 2007 Mar 28;297(12):1344-53. Epub 2007 Mar 25
  • DOI: 10.1001/jama.297.12.1344
  • Espeland M.A., O'leary D.H., Terry J.G, Morgan T., Evans G., Mudra H. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med. 2005; 6(1): 3
  • DOI: 10.1186/1468-6708-6-3
  • Reiner Z., Catapano A.L., De B.G. et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011;32:1769-1818.
  • Baigent C., Blackwell L., Emberson J. et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670-1681.
  • Perk J., De B.G., Gohlke H. et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis 2012;223:1-68].
  • Brunzell J.D., Davidson M., Furberg C.D et al. Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation, Diabetes Care, 2008, 811-822,
  • DOI: 10.2337/dc08-9018
  • Minhas R., Humphries S.E., Davies D. et al. UK NICE Guideline on Identification and Management of FH (CG71). Internet. http://www.nice.org.uk/CG071 (30 March 2013.
  • Sillesen H., Amarenco P., Hennerici M.G. et al. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008;39:3297-3302. 10.1161/StrokeAHA.108.516450
  • DOI: :10.1161/STROKEAHA.108.516450
  • Amarenco P., Bogousslavsky J., Callahan A. 3rd et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006 Aug 10;355(6):549-59
  • DOI: 10.1056/NEJMoa061894
  • Josephson S.A., Bryant S.O., Mak H.K. et al. Evaluation of carotid stenosis using CT angiography in the initial evaluation of stroke and TIA. Neurology. 2004;63:457-460
  • Wagenknecht L.E., Zaccaro D., Espeland M.A. et al. Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol. 2003; 23: 1035-41
  • DOI: 10.1161/01.ATV.0000072273.67342.6D
  • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002 Jul 6;360(9326):7-22
  • DOI: 10.1016/S0140-6736(02)09327-3
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp